Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review.

Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review.

BACKGROUND: To date, there has been no systematic examination of the relationship between international normalized ratio (INR) control measurements and the prediction of adverse events in patients with atrial fibrillation on oral anticoagulation. METHODS AND RESULTS: We searched MEDLINE, EMBASE, an...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Wan, Y, Heneghan, C, Perera, R, Roberts, N, Hollowell, J, Glasziou, P, Bankhead, C, Xu, Y
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2008

Míreanna comhchosúla

Adverse events in clinically complex elderly patients with atrial fibrillation according to oral anticoagulation statusResearch in context
de réir: Tommaso Bucci, et al.
Foilsithe / Cruthaithe: (2024-12-01)

Rhythm control agents and adverse events in patients with atrial fibrillation.
de réir: Taylor, C, et al.
Foilsithe / Cruthaithe: (2010)

Individualised prediction of major bleeding in patients with atrial fibrillation treated with anticoagulation
de réir: Anne Pernille Toft-Petersen, et al.
Foilsithe / Cruthaithe: (2024-01-01)

Individualised prediction of major bleeding in patients with atrial fibrillation treated with anticoagulation.
de réir: Anne Pernille Toft-Petersen, et al.
Foilsithe / Cruthaithe: (2024-01-01)

Anticoagulant management in patients with atrial fibrillation.
de réir: Fitzmaurice, D, et al.
Foilsithe / Cruthaithe: (2009)

Machine Learning Approaches to Predict Major Adverse Cardiovascular Events in Atrial Fibrillation
de réir: Pedro Moltó-Balado, et al.
Foilsithe / Cruthaithe: (2024-01-01)

3021 Haemodialysis and atrial fibrillation anticoagulation decisions
de réir: Stephen Bacchi, et al.
Foilsithe / Cruthaithe: (2024-08-01)

Effects of Anticoagulant Therapy and Frailty in the Elderly Patients with Atrial Fibrillation
de réir: Ding J, et al.
Foilsithe / Cruthaithe: (2024-02-01)

Coffee consumption and adverse cardiovascular events in patients with atrial fibrillation
de réir: Vasco Iten, et al.
Foilsithe / Cruthaithe: (2024-12-01)

Time trends in atrial fibrillation-associated stroke and premorbid anticoagulation
de réir: Yiin, G, et al.
Foilsithe / Cruthaithe: (2018)

The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
de réir: I. Yu. Koroleva, et al.
Foilsithe / Cruthaithe: (2016-11-01)

Algorithm for the Choice of Anticoagulant for Patients with Atrial Fibrillation
de réir: Yu. P. Skirdenko, et al.
Foilsithe / Cruthaithe: (2020-05-01)

Atrial Fibrillation Ablation without Interruption of Anticoagulation
de réir: Pasquale Santangeli, et al.
Foilsithe / Cruthaithe: (2011-01-01)

Challenging anticoagulation decisions in atrial fibrillation: a narrative review
de réir: Michael Griffin, et al.
Foilsithe / Cruthaithe: (2024-10-01)

Biomarkers for Predicting Left Atrial or Left Atrial Appendage Thrombus in Anticoagulated Patients with Nonvalvular Atrial Fibrillation
de réir: Xue Zhou, et al.
Foilsithe / Cruthaithe: (2020-01-01)

A systematic review of economic aspects of service interventions to increase anticoagulation use in atrial fibrillation
de réir: Jones, NR, et al.
Foilsithe / Cruthaithe: (2021)

Underuse of anticoagulation for atrial fibrillation - are we failing our patients?
de réir: Jones, N, et al.
Foilsithe / Cruthaithe: (2017)

Atrial fibrillation – NICE 2021 update and the focus on anticoagulation
de réir: Jones, N, et al.
Foilsithe / Cruthaithe: (2022)

CURRENT POSSIBILITIES OF ANTICOAGULANT THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION
de réir: M. Yu. Gilyarov, et al.
Foilsithe / Cruthaithe: (2015-10-01)

Anticoagulation therapy in atrial fibrillation after intracranial hemorrhage
de réir: A. S. Gerasimenko, et al.
Foilsithe / Cruthaithe: (2021-05-01)

Challenges of anticoagulant treatment in atrial fibrillation with liver disease
de réir: Alina Doina Nicoara, et al.
Foilsithe / Cruthaithe: (2024-10-01)

Anticoagulant therapy in catheter ablation of atrial fibrillation and flutter
de réir: M. V. Serova, et al.
Foilsithe / Cruthaithe: (2021-09-01)

Anticoagulation for Atrial Fibrillation in Acute Coronary Syndrome Survivors Reduces Major Cardiovascular Events and Mortality
de réir: Łukasz Pyka MD, PhD, et al.
Foilsithe / Cruthaithe: (2023-12-01)

Self-monitoring of oral anticoagulation: a systematic review and meta-analysis.
de réir: Heneghan, C, et al.
Foilsithe / Cruthaithe: (2006)

Sex-specific comparative outcomes between oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis
de réir: Gregory Y H Lip, et al.
Foilsithe / Cruthaithe: (2024-08-01)

Left Atrial Appendage Closure in Atrial Fibrillation: A World without Anticoagulation?
de réir: Tahmeed Contractor, et al.
Foilsithe / Cruthaithe: (2011-01-01)

Moderate/severe biatrial dilation predicts adverse events after ablation in atrial fibrillation with heart failure
de réir: Yan Yao, et al.
Foilsithe / Cruthaithe: (2024-10-01)

Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF)
de réir: Raffaele De Caterina, et al.
Foilsithe / Cruthaithe: (2019-03-01)

PREDICTORS OF THE RISK OF HEMORRHAGIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION RECEIVING LONGTERM THERAPY WITH DIRECT ORAL ANTICOAGULANTS
de réir: A. А. Sokolova, et al.
Foilsithe / Cruthaithe: (2017-12-01)

Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials
de réir: Jennifer R. Brown, et al.
Foilsithe / Cruthaithe: (2017-10-01)

Challenges of anticoagulant therapy in patients with atrial fibrillation in clinical practice.
de réir: Hobbs, R
Foilsithe / Cruthaithe: (2012)

ANTICOAGULATION IN PATIENTS WITH ATRIAL-FIBRILLATION - EXPERT SOFTWARE MAY BE THE ANSWER
de réir: Fitzmaurice, D, et al.
Foilsithe / Cruthaithe: (1994)

Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Renal Dysfunction
de réir: Z. D. Kobalava, et al.
Foilsithe / Cruthaithe: (2021-03-01)

THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY
de réir: M. Yu. Gilyarov
Foilsithe / Cruthaithe: (2015-12-01)

Type 2 Diabetes, Atrial Fibrillation, and Direct Oral Anticoagulation
de réir: Dana Prídavková, et al.
Foilsithe / Cruthaithe: (2019-01-01)

Factors determining adherence to anticoagulant therapy in patients with atrial fibrillation
de réir: D. V. Pevzner, et al.
Foilsithe / Cruthaithe: (2023-06-01)

Specifics of anticoagulation in combination with atrial fibrillation and chronic kidney disease
de réir: N. Sh. Zagidullin, et al.
Foilsithe / Cruthaithe: (2021-10-01)

NOVEL ANTICOAGULANTS FOR THROMBOEMBOLIC COMPLICATIONS PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION
de réir: D. A. Itkin, et al.
Foilsithe / Cruthaithe: (2015-02-01)

Contribution of anticoagulant therapy adherence to the risk of complications of atrial fibrillation
de réir: Yu. P. Skirdenko, et al.
Foilsithe / Cruthaithe: (2019-03-01)

New safety standards for anticoagulant therapy in the treatment of atrial fibrillation
de réir: E. I. Baranova
Foilsithe / Cruthaithe: (2018-11-01)